02393.HK
Yestar Healthcare Holdings Company Limited
HKSE · Healthcare · Medical - Devices · CN
HKD 0.07
+6.45%Year over year
Reported trailing growth
- Revenue
- -30.4%
- EBITDA
- +156.2%
- EBIT
- +102.5%
- EPS
- +48.1%
- Free cash flow
- +20.8%
- Operating cash flow
- +14.1%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -19.0%
- EBITDA
- +25.3%
- EBIT
- -92.7%
- Net income
- —
- EPS
- —
- Free cash flow
- -0.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026